Latest stories on NKTX
Nkarta, Inc. (NKTX) files 8-K
SEC 8-K50 · neutralgeneral
Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026
GlobeNewswire53 · neutralproduct/pr
Nkarta to Host Webcast to Discuss Initial Clinical Data for NKX019 in Autoimmune Diseases at ACR Convergence 2026
StockTitan56 · neutralproduct/pr
Nkarta GAAP EPS of -$0.45 misses by $0.03
Seeking Alpha38 · neutralearnings
Nkarta reports Q3 EPS (45c), consensus (38c)
The Fly38 · neutralearnings
Nkarta, Inc. (NKTX) files 8-K
SEC 8-K50 · neutralgeneral
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
Business Insider58 · neutralearnings
Nkarta Reports Third Quarter 2026 Financial Results and Provides Business Update
GlobeNewswire58 · neutralearnings
H.C. Wainwright initiates Nkarta stock coverage with buy rating
Investing.com Analyst Ratings63 · neutralanalyst
Nkarta assumed with a Buy at H.C. Wainwright
The Fly63 · neutralanalyst
Nkarta to Participate in September Investor Conferences
GlobeNewswire56 · neutralgeneral
Nkarta to Participate in September Investor Conferences
Business Insider56 · neutralgeneral
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
StockTitan63 · neutralproduct/pr
Nkarta to Present Initial Autoimmune Clinical Data for NKX019 at American College of Rheumatology (ACR) Convergence 2026
GlobeNewswire63 · neutralproduct/pr
Nkarta: 'Hold' NKX019 Discontinuation For R/R NHL And Pivot To Autoimmune Disorders
Seeking Alpha48 · neutralgeneral
Nkarta price target lowered to $10 from $11 at Stifel
The Fly34 · bearishanalyst
Stifel cuts Nkarta stock price target on updated model
Investing.com Analyst Ratings34 · bearishanalyst
Nkarta price target lowered to $14 from $16 at H.C. Wainwright
The Fly38 · neutralanalyst
Nkarta Reports Q2 Eps 54c Consensus 36c
The Fly66 · bullishearnings
Nkarta GAAP EPS of -$0.54 misses by $0.16
Seeking Alpha34 · bearishearnings
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
Business Insider50 · neutralearnings
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights
StockTitan56 · neutralearnings
Nkarta, Inc. (NKTX) files 8-K
SEC 8-K50 · neutralgeneral
Nkarta to Participate in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference | NKTX Stock News
StockTitan57 · neutralproduct/pr